A common presentation - turning out as an uncommon diagnosis: From hip pain to Langerhans cell histiocytosis.

Adult Langerhans cell histiocytosis BRAF High risk Langerhans cell histiocytosis Lytic lesions Multi-system Langerhans cell histiocytosis

Journal

The American journal of the medical sciences
ISSN: 1538-2990
Titre abrégé: Am J Med Sci
Pays: United States
ID NLM: 0370506

Informations de publication

Date de publication:
09 2022
Historique:
received: 19 06 2021
revised: 28 02 2022
accepted: 14 04 2022
pubmed: 27 4 2022
medline: 9 9 2022
entrez: 26 4 2022
Statut: ppublish

Résumé

Langerhans cell histiocytosis (LCH) is an uncommon clonal proliferation of myeloid progenitor cells, it is especially rare in adults. We present a case of multi-system LCH in a 53-year-old woman, the sole symptom of which was prolonged, non-resolving hip pain for 18 months prior to the diagnosis. Initial evaluation included imaging studies aimed at identifying a presumed local etiology. X-ray demonstrated non-specific arthritic changes on the left femur. Computed tomography (CT) and magnetic resonance imaging (MRI) scans identified a lytic lesion at the same location, warranting a systemic workup. After non-invasive investigations failed to reveal the underlying etiology, a biopsy was performed, revealing cores of Langerhans cells that stained positive for both CD1a and langerin. These findings verified the surprising, uncommon diagnosis of LCH. A comprehensive workup was conducted in order to determine the extent of the disease and its molecular nature - revealing a BRAF

Identifiants

pubmed: 35472335
pii: S0002-9629(22)00173-2
doi: 10.1016/j.amjms.2022.04.014
pii:
doi:

Types de publication

Case Reports Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

353-358

Informations de copyright

Copyright © 2022 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The Authors declare that there is no conflict of interest.

Auteurs

Ina Volis (I)

Department of Internal Medicine "A", Rambam Health Care Campus, Haifa 3109601, Israel; The Rappaport Faculty of Medicine and Research Institute, Technion - Israel Institute of Technology, Haifa 3109602, Israel; Department of Cardiology, Rambam Health Care Campus, Haifa, Israel. Electronic address: ina.volis@gmail.com.

Ido Livneh (I)

The Rappaport Faculty of Medicine and Research Institute, Technion - Israel Institute of Technology, Haifa 3109602, Israel. Electronic address: idoliv@campus.technion.ac.il.

Yaniv Zohar (Y)

The Rappaport Faculty of Medicine and Research Institute, Technion - Israel Institute of Technology, Haifa 3109602, Israel; Department of Pathology, Rambam Health Care Campus, Haifa, Israel. Electronic address: y_zohar@rambam.health.gov.il.

Ayelet Raz-Pasteur (A)

Department of Internal Medicine "A", Rambam Health Care Campus, Haifa 3109601, Israel; The Rappaport Faculty of Medicine and Research Institute, Technion - Israel Institute of Technology, Haifa 3109602, Israel. Electronic address: a_raz@rambam.health.gov.il.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH